Evidence map›Paper›PMID 35106311›Full record

ArticleOpen forum infectious diseases2022

Alarming Tuberculosis Rate Among People Who Inject Drugs in Vietnam.

Nicolas Nagot, Vinh Vu Hai, Thuy Thi Thu Dong, Oanh Khuat Thi Hai, Delphine Rapoud, Giang Thi Hoang, Catherine Quillet, Khue Pham Minh, Roselyne Vallo, Thanh Tuyet Thi Nham and 10 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 3 countries.

Nicolas NagotPathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles-Guyane, Montpellier, France.
Vinh Vu HaiInfectious and Tropical Diseases Department, Viet Tiep Hospital, Hai Phong, Vietnam.
Thuy Thi Thu DongFriends for International TB relief, Hanoi, Vietnam.
Oanh Khuat Thi HaiSupporting Community Development Initiatives, Hanoi, Vietnam.
Delphine RapoudPathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles-Guyane, Montpellier, France.
Giang Thi HoangDepartment of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Catherine QuilletPathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles-Guyane, Montpellier, France.
Khue Pham MinhDepartment of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Roselyne ValloPathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles-Guyane, Montpellier, France.
Thanh Tuyet Thi NhamSupporting Community Development Initiatives, Hanoi, Vietnam.
Joëlle CastellaniPathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles-Guyane, Montpellier, France.
Jonathan FeelemyerSchool of Global Public Health, New York University, New York, New York, USA.
Don C Des JarlaisSchool of Global Public Health, New York University, New York, New York, USA.
Lan Phuong NguyenFriends for International TB relief, Hanoi, Vietnam.
Hoi Van LeNational TB control program, Hanoi, Vietnam.
Nhung Viet NguyenNational TB control program, Hanoi, Vietnam.
Luan Nguyen Quang VoFriends for International TB relief, Hanoi, Vietnam.
Huong Thi DuongDepartment of Public Health, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.
Jean-Pierre MolesPathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles-Guyane, Montpellier, France.
Didier LaureillardPathogenesis and Control of Chronic & Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang, University of Antilles-Guyane, Montpellier, France.
Établissement Français du Sang · FRInserm · FRCenter for Creative Initiatives in Health and Population · VNHai phong University Of Medicine and Pharmacy · VNNew York University · USHai Phong University · VNHung Vuong Hospital · VNUniversité de Montpellier · FR

Funding

DRIVE (DRug use and blood-borne Infections in ViEtnam): Combined prevention and care to end the HIV epidemic among people who inject drugs in Haiphong, Viet NamR01DA041978 · NIDA · NEW YORK UNIVERSITY · PI DES JARLAIS, DON C · 2016 to 2020
$4.9M
NIDA NIH HHS R01 DA041978
6 · The paper itself

Abstract

backgroundThe tuberculosis (TB) epidemic is not homogeneous in the general population but presents high-risk groups. People who inject drugs (PWID) are such a group. However, TB among PWID remains largely undocumented. Our goal was to assess the prevalence of TB and the risk factors associated with TB among PWID in Vietnam.

methodsWe implemented a cross-sectional survey among 2 community-based cohorts of human immunodeficiency virus (HIV)-positive and HIV-negative PWID in Hai Phong. Participants were screened for TB using questions on TB symptoms. Those who reported any symptom were accompanied by peers to the TB clinic for chest x-ray. If the latter was abnormal, a sputum was collected to perform an Xpert MTB/RIF test.

resultsA total of 885 PWID were screened for TB. For both cohorts, most PWID were male (>90.0%), with a median age of 42 years. Beside heroin injection, 52.5% of participants reported smoking methamphetamine, and 63.2% were on methadone. Among HIV-positive PWID (N = 451), 90.4% were on antiretroviral therapy and 81.6% had a viral load <1000 copies/mL. Using a complete-case analysis, the estimated TB prevalence was 2.3% (95% confidence interval [CI], 1.0-4.5) and 2.1% (95% CI, 0.8-4.2) among HIV-positive and HIV-negative people, respectively. Living as a couple, arrest over the past 6 months, homelessness, and smoking methamphetamine were independently associated with TB but not HIV infection.

conclusionsIn the context of very large antiretroviral therapy coverage, this extremely high rate of TB among PWID requires urgent actions.

Indexed as

drug usersepidemiologyprevalencerisk factorstuberculosis

Identifiers

PMID35106311
PMCPMC8801226
OpenAlexW3212843561

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.